210 related articles for article (PubMed ID: 11354321)
21. High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer.
Foekens JA; Peters HA; Grebenchtchikov N; Look MP; Meijer-van Gelder ME; Geurts-Moespot A; van der Kwast TH; Sweep CG; Klijn JG
Cancer Res; 2001 Jul; 61(14):5407-14. PubMed ID: 11454684
[TBL] [Abstract][Full Text] [Related]
22. [Preoperative hemodilution before elective resections of colorectal cancers for sparing homologous blood transfusion].
Graupe F; Böhm B; Hucke HP; Stock W
Leber Magen Darm; 1992 May; 22(3):111-5. PubMed ID: 1625508
[TBL] [Abstract][Full Text] [Related]
23. Correlation of plasma level and immunohistochemical expression of vascular endothelial growth factor in patients with advanced colorectal cancer.
Minagawa N; Nakayama Y; Hirata K; Onitsuka K; Inoue Y; Nagata N; Itoh H
Anticancer Res; 2002; 22(5):2957-63. PubMed ID: 12530025
[TBL] [Abstract][Full Text] [Related]
24. Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1.
Lissoni P; Malugani F; Bonfanti A; Bucovec R; Secondino S; Brivio F; Ferrari-Bravo A; Ferrante R; Vigoré L; Rovelli F; Mandalà M; Viviani S; Fumagalli L; Gardani GS
J Biol Regul Homeost Agents; 2001; 15(2):140-4. PubMed ID: 11501971
[TBL] [Abstract][Full Text] [Related]
25. Soluble FLT-1 is detectable in the sera of colorectal and breast cancer patients.
Kumar H; Heer K; Greenman J; Kerin MJ; Monson JR
Anticancer Res; 2002; 22(3):1877-80. PubMed ID: 12168886
[TBL] [Abstract][Full Text] [Related]
26. [Perioperative blood transfusion and prognosis in colorectal cancer. Analysis of a series].
Fernández Fernández L; Sanz Anquela M; Ratia T; Tejero E; Tieso A; Alfaro J; Ruiz JM
Rev Esp Enferm Dig; 1992 Nov; 82(5):317-24. PubMed ID: 1485983
[TBL] [Abstract][Full Text] [Related]
27. Prognosis and postoperative lymphocyte count in patients with hepatocellular carcinoma who received intraoperative allogenic blood transfusion: a retrospective study.
Sugita S; Sasaki A; Iwaki K; Uchida H; Kai S; Shibata K; Ohta M; Kitano S
Eur J Surg Oncol; 2008 Mar; 34(3):339-45. PubMed ID: 17400417
[TBL] [Abstract][Full Text] [Related]
28. [Expression of vascular endothelial growth factor in colorectal cancer and its clinical significance].
Han J; Xia C; Gao J; Xing C; Yang X; Tang X; Qiu F; Du Y
Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(7):481-3. PubMed ID: 12133521
[TBL] [Abstract][Full Text] [Related]
29. The effect of preoperative blood transfusion on morbidity and survival in colorectal malignancy.
Nursal TZ; Hamaloğlu E
Turk J Gastroenterol; 2006 Dec; 17(4):283-7. PubMed ID: 17205407
[TBL] [Abstract][Full Text] [Related]
30. [Determination of vascular endothelial growth factor (VEGF) concentration in serum of patients with colorectal carcinoma].
Broll R; Erdmann H; Windhövel U; Duchrow M; Strik MW
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):315-8. PubMed ID: 14518267
[TBL] [Abstract][Full Text] [Related]
31. Effects of IL-2 preoperative immunotherapy on surgery-induced changes in angiogenic regulation and its prevention of VEGF increase and IL-12 decline.
Brivio F; Lissoni P; Rovelli F; Nespoli A; Uggeri F; Fumagalli L; Gardani G
Hepatogastroenterology; 2002; 49(44):385-7. PubMed ID: 11995457
[TBL] [Abstract][Full Text] [Related]
32. Systemic inflammatory response predicts survival following curative resection of colorectal cancer.
McMillan DC; Canna K; McArdle CS
Br J Surg; 2003 Feb; 90(2):215-9. PubMed ID: 12555298
[TBL] [Abstract][Full Text] [Related]
33. Perioperative blood transfusion and survival following curative hepatic resection for hepatocellular carcinoma.
Hanazaki K; Kajikawa S; Shimozawa N; Matsushita A; Machida T; Shimada K; Yazawa K; Koide N; Adachi W; Amano J
Hepatogastroenterology; 2005; 52(62):524-9. PubMed ID: 15816471
[TBL] [Abstract][Full Text] [Related]
34. Comparison of multivisceral resection and standard operation for locally advanced colorectal cancer: analysis of prognostic factors for short-term and long-term outcome.
Nakafusa Y; Tanaka T; Tanaka M; Kitajima Y; Sato S; Miyazaki K
Dis Colon Rectum; 2004 Dec; 47(12):2055-63. PubMed ID: 15657654
[TBL] [Abstract][Full Text] [Related]
35. Preoperative iron supplementation and intraoperative transfusion during colorectal cancer surgery.
Okuyama M; Ikeda K; Shibata T; Tsukahara Y; Kitada M; Shimano T
Surg Today; 2005; 35(1):36-40. PubMed ID: 15622462
[TBL] [Abstract][Full Text] [Related]
36. Circular tumor growth: a prognostic factor in stage II colorectal carcinoma.
Jimi S; Hotokezaka M; Eto TA; Hidaka H; Maehara N; Chijiiwa K
Hepatogastroenterology; 2008; 55(84):926-9. PubMed ID: 18705299
[TBL] [Abstract][Full Text] [Related]
37. Blood transfusion and recurrence of colorectal cancer.
Modin S; Karlsson G; Wählby L; Wählby L
Eur J Surg; 1992; 158(6-7):371-5. PubMed ID: 1356471
[TBL] [Abstract][Full Text] [Related]
38. Prediction of postoperative survival by preoperative serum concentrations of anti-p53 compared to CEA, CA 50, CA 242 and conventional blood tests in patients with colorectal carcinoma.
Forslund A; Engarås B; Lönnroth C; Lundholm K
Int J Oncol; 2002 May; 20(5):1013-8. PubMed ID: 11956598
[TBL] [Abstract][Full Text] [Related]
39. Peri-operative blood transfusions in colorectal cancer.
Vente JP; Wiggers T; Weidema WF; Jeekel J; Obertop H
Eur J Surg Oncol; 1989 Aug; 15(4):371-4. PubMed ID: 2668037
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone-refractory prostate cancer treated on Cancer and Leukemia Group B 9480.
George DJ; Halabi S; Shepard TF; Vogelzang NJ; Hayes DF; Small EJ; Kantoff PW;
Clin Cancer Res; 2001 Jul; 7(7):1932-6. PubMed ID: 11448906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
